Charles River Laboratories Debt/Equity Ratio 2010-2024 | CRL

Charles River Laboratories debt/equity ratio for the quarter ending June 30, 2024 was 0.65.

  • Charles River Laboratories average debt/equity ratio for 2023 was 0.8, a 23.81% decline from 2022.
  • Charles River Laboratories average debt/equity ratio for 2022 was 1.05, a 5.41% decline from 2021.
  • Charles River Laboratories average debt/equity ratio for 2021 was 1.11, a 4.31% decline from 2020.

Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.

Charles River Laboratories Debt/Equity Ratio 2010-2024 | CRL

  • Charles River Laboratories average debt/equity ratio for 2023 was 0.8, a 23.81% decline from 2022.
  • Charles River Laboratories average debt/equity ratio for 2022 was 1.05, a 5.41% decline from 2021.
  • Charles River Laboratories average debt/equity ratio for 2021 was 1.11, a 4.31% decline from 2020.

Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.